Skip to content

Parcus GFS BTB

by Parcus Medical LLC

510(k) K183331

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK183331 Date7 Feb 2019ClearedStatusActive

Official records

From the FDA record

Received by the FDA
3 Dec 2018
FDA decision
7 Feb 2019 (Substantially Equivalent)
FDA review time
66 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K183331 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MBI
FDA applicant
Parcus Medical, LLC
Device class
Class II
Regulation
21 CFR Part 888.3040
Advisory committee
Orthopedic
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Parcus GFS BTB is a ligament retention device classified as a fastener, fixation, nondegradable, soft tissue device under the MBI product code. It is designed for mechanical fixation of ligaments and tendons, providing secure anchoring of grafts in orthopedic procedures. Constructed from medical-grade titanium and ultra-high-molecular-weight polyethylene (UHMWPE) suture, it is intended for use in conjunction with other Parcus Medical fixation systems, such as the GFS Ultimate, GFS Mini, and GFS II.

This device is supplied sterile and is operated by surgeons in clinical or surgical settings. It is classified as a Class II medical device under FDA Special Controls and received FDA 510(k) clearance (K183331) on February 7, 2019, following a review by the Orthopedic (OR) Advisory Committee. The device is intended for single-use applications, though regulatory status and reuse instructions are not specified in the provided data.

Similar devices

Other devices filed under FDA product code MBI (Fastener, Fixation, Nondegradable, Soft Tissue).

Other devices from Parcus Medical LLC

See all devices from Parcus Medical LLC →